Scarica l'app Stockscreener
19.23
0.58%
0.11
Dopo l'orario di chiusura:
19.33
0.10
+0.52%
Seres Therapeutics Inc Borsa (MCRB) Ultime notizie
How Seres Therapeutics Inc. (1S90) stock moves on employment dataMarket Performance Recap & Stock Timing and Entry Methods - newser.com
News impact scoring models applied to Seres Therapeutics Inc.CPI Data & Fast Gaining Stock Strategy Reports - newser.com
Is Seres Therapeutics Inc. stock a contrarian buyAnalyst Downgrade & Weekly Watchlist for Hot Stocks - newser.com
Vontobel Holding Ltd. Has $892,000 Holdings in Seres Therapeutics, Inc. $MCRB - MarketBeat
Will Seres Therapeutics Inc. stock benefit from infrastructure spendingMarket Performance Report & High Accuracy Trade Alerts - newser.com
Is Seres Therapeutics Inc. stock supported by innovation pipelineMarket Movement Recap & Consistent Profit Trade Alerts - newser.com
Seres Therapeutics soars on report of takeover offer - MSN
Exit strategy if you’re trapped in Seres Therapeutics Inc.Weekly Trading Summary & Expert Verified Movement Alerts - newser.com
Is Seres Therapeutics Inc. forming a bottoming baseTreasury Yields & Long-Term Growth Plans - newser.com
Can you recover from losses in Seres Therapeutics Inc.Weekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Quantitative breakdown of Seres Therapeutics Inc. recent moveCPI Data & Stepwise Swing Trade Plans - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Is it too late to sell Seres Therapeutics Inc.2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Seres Therapeutics (NASDAQ:MCRB) Receives "Sell (D+)" Rating from Weiss Ratings - MarketBeat
Building trade automation scripts for Seres Therapeutics Inc.July 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Analysts Set Seres Therapeutics, Inc. (NASDAQ:MCRB) Target Price at $14.33 - Defense World
Technical signs of recovery in Seres Therapeutics Inc.July 2025 Trends & Verified Momentum Watchlists - newser.com
Seres Therapeutics Inc. stock retracement – recovery analysisMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
How high can Seres Therapeutics Inc. stock goMarket Activity Summary & Daily Momentum Trading Reports - newser.com
Published on: 2025-10-05 04:28:16 - newser.com
Understanding Seres Therapeutics Inc.’s price movementJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Is Seres Therapeutics Inc. a candidate for recovery playJuly 2025 Update & Daily Entry Point Alerts - newser.com
Seres Therapeutics announces workforce reduction to extend cash runway - Investing.com
Seres Therapeutics Cuts Costs to Extend Cash Runway - TipRanks
Dated alerts on Seres Therapeutics' measures to cut costs withdrawn - MarketScreener
Developing predictive dashboards with Seres Therapeutics Inc. dataWeekly Earnings Recap & AI Enhanced Trading Signals - newser.com
Using data tools to time your Seres Therapeutics Inc. exit2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-03 00:05:20 - newser.com
Is Seres Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Outperform the Market with Aggressive Picks - earlytimes.in
Goldman Sachs Group Inc. Acquires 21,679 Shares of Seres Therapeutics, Inc. $MCRB - MarketBeat
What analysts say about Seres Therapeutics Inc stockInstitutional Holding Changes & Capitalize On Fast Trends - earlytimes.in
What drives Seres Therapeutics Inc stock priceMoving Average Crossovers & Master Technical Analysis With Free Tools - earlytimes.in
What earnings revisions data tells us about Seres Therapeutics Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Using portfolio simulators with Seres Therapeutics Inc. includedPortfolio Return Report & Consistent Income Trade Ideas - newser.com
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):